Cardiovascular Pathology
Volume 19, Issue 2 , Pages 102-111 , March 2010

Atrial fibrillation is associated with cardiac hypoxia

  • Felix Gramley

      Affiliations

    • Department of Cardiology and Vascular Medicine, Mainz University, Germany
    • Corresponding Author InformationCorresponding author. Department of Cardiology and Vascular Medicine, University Hospital Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. Tel.: +49 6131 170.
    • ,
  • Johann Lorenzen

      Affiliations

    • Institute for Pathology, RWTH Aachen University, Germany
    • ,
  • Britta Jedamzik

      Affiliations

    • Institute for Pathology, RWTH Aachen University, Germany
    • ,
  • Kevin Gatter

      Affiliations

    • Nuffield Department of Clinical Laboratory Sciences, Oxford University, UK
    • ,
  • Eva Koellensperger

      Affiliations

    • Department for Plastic and Hand Surgery, University of Heidelberg, Germany
    • ,
  • Thomas Munzel

      Affiliations

    • Department of Cardiology and Vascular Medicine, Mainz University, Germany
    • ,
  • Francesco Pezzella

      Affiliations

    • Nuffield Department of Clinical Laboratory Sciences, Oxford University, UK

Received 8 January 2008 ,Revised 2 November 2008 ,Accepted 18 November 2008.

References 

  1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(8A):2N–9N
  2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988
  3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–952
  4. Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation. 2002;105(22):2672–2678
  5. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100(1):87–95
  6. Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107(14):1930–1936
  7. De Boer RA, Pinto YM, Van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation. 2003;10(2):113–126
  8. Thijssen VL, van der Velden HM, van Ankeren EP, Ausma J, Allessie MA, Borgers M, et al. Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc Res. 2002;54(2):427–437
  9. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669–676
  10. Harris AL. Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38–47
  11. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 2003;17(9):984–992
  12. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990;82(3):792–797
  13. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem. 1981;112(1):70–75
  14. Neuman RE, Logan MA. The determination of collagen and elastin in tissues. J Biol Chem. 1950;186(2):549–556
  15. Oken DE, Boucek RJ. Quantitation of collagen in human myocardium. Circ Res. 1957;5(4):357–361
  16. Stewart M, Talks K, Leek R, Turley H, Pezzella F, Harris A, et al. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology. 2002;40(3):253–260
  17. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer. 1996;73(3):275–280
  18. Stewart M, Turley H, Cook N, Pezzella F, Pillai G, Ogilvie D, et al. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology. 2003;43(1):33–39
  19. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000;157(2):411–421
  20. Gramley F, Lorenzen J, Plisiene J, Rakauskas M, Benetis R, Schmid M, et al. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(10):1076–1082
  21. Wong AK, Marais HJ, Jutzy K, Capestany GA, Marais GE. Isolated atrial infarction in a patient with single vessel disease of the sinus node artery. Chest. 1991;100(1):255–256
  22. Lammers WJ, Kirchhof C, Bonke FI, Allessie MA. Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol. 1992;262(1 Pt 2):H47–H55
  23. Bunc M, Starc R, Podbregar M, Brucan A. Conversion of atrial fibrillation into a sinus rhythm by coronary angioplasty in a patient with acute myocardial infarction. Eur J Emerg Med. 2001;8(2):141–145
  24. Kochiadakis GE, Skalidis EI, Kalebubas MD, Igoumenidis NE, Chrysostomakis SI, Kanoupakis EM, et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J. 2002;23(9):734–741
  25. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104(2):174–180
  26. Vester EG. Myocardial ischemia and ventricular arrhythmia. Z Kardiol. 1998;87(Suppl 2):49–60
  27. Nattel S. Atrial electrophysiology and mechanisms of atrial fibrillation. J Cardiovasc Pharmacol Ther. 2003;8(Suppl 1):S5–S11
  28. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60(24):7075–7083
  29. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551–578
  30. Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007;4(3 Suppl):S24–S27
  31. Li X, Ma C, Dong J, Liu X, Long D, Tian Y, et al. The fibrosis and atrial fibrillation: is the transforming growth factor-beta(1) a candidate etiology of atrial fibrillation. Med Hypotheses. 2008;70(2):317–319
  32. Seko Y, Nishimura H, Takahashi N, Ashida T, Nagai R. Serum levels of vascular endothelial growth factor and transforming growth factor-beta1 in patients with atrial fibrillation undergoing defibrillation therapy. Jpn Heart J. 2000;41(1):27–32
  33. Schotten U, Neuberger HR, Allessie MA. The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol. 2003;82(1–3):151–162
  34. Inaba Y, Yuda S, Kobayashi N, Hashimoto A, Uno K, Nakata T, et al. Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr. 2005;18(7):729–736
  35. Kokubu N, Yuda S, Tsuchihashi K, Hashimoto A, Nakata T, Miura T, et al. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin–angiotensin system inhibition on left atrial function. Hypertens Res. 2007;30(1):13–21
  36. Epstein ND, Davis JS. Sensing stretch is fundamental. Cell. 2003;112(2):147–150
  37. Kim CH, Cho YS, Chun YS, Park JW, Kim MS. Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res. 2002;90(2):E25–E33
  38. Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100(1):18–24
  39. Lip GY. Does atrial fibrillation confer a hypercoagulable state?. Lancet. 1995;346(8986):1313–1314
  40. Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?. Stroke. 2002;33(9):2187–2191
  41. Roldan V, Marin F, Marco P, Martinez JG, Calatayud R, Sogorb F. Hypofibrinolysis in atrial fibrillation. Am Heart J. 1998;136(6):956–960
  42. Freestone B, Chong A, Lim H, Blann A, Lip G. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?. Ann Med. 2005;37(5):365–372
  43. Choudhury A, Freestone B, Patel J, Lip G. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?. Chest. 2007;32(6):1913–1919
  44. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin–proteasome pathway. J Biol Chem. 1999;274(10):6519–6525
  45. Feng Y, Venema VJ, Venema RC, Tsai N, Caldwell RB. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun. 1999;256(1):192–197
  46. Moroianu J, Riordan JF. Nuclear translocation of angiogenic proteins in endothelial cells: an essential step in angiogenesis. Biochemistry. 1994;33(42):12535–12539
  47. Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer. 2000;83(1):63–68
  48. Jesmin S, Hattori Y, Togashi H, Ueno K, Yoshioka M, Sakuma I. Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats. Mol Cell Biochem. 2005;272(1–2):63–73
  49. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A, et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation. 2004;109(8):1029–1035
  50. von Degenfeld G, Banfi A, Springer ML, Blau HM. Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. Br J Pharmacol. 2003;140(4):620–626
  51. Zhao L, Eghbali-Webb M. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim Biophys Acta. 2001;1538(2–3):273–282
  52. Liu W, Ahmad SA, Reinmuth N, Shaheen RM, Jung YD, Fan F, et al. Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis. 2000;5(4):323–328

PII: S1054-8807(08)00171-3

doi: 10.1016/j.carpath.2008.11.001

Cardiovascular Pathology
Volume 19, Issue 2 , Pages 102-111 , March 2010

Article Tools

* Image Usage & Resolution